The importance of glucagon on postoperative changes in hepatic amino-nitrogen conversion were investigated in six patients undergoing elective cholecystectomy for uncomplicated gall stones. Patients were given infusions of somatostatin (bolus of 6 ig/klg foliowed by continuous infusion of 6 jig/kg/h) from induction of anaesthesia to the end of investigation, the first postoperative day (30 hours). Controls were 16 patients undergoing the same procedures omitting the somatostatin infusion. In all patients blood concentration and plasma clearance of total a-amino-nitrogen, and amino acid stimulated rate of urea synthesis were measured. Elective cholecystectomy decreased blood a-amino-nitrogen concentration from mean (SEM) 2-9 (0.2) to 2-4 (0.1) mmol/l (p<0.05), increased the clearance of total a-amino-nitrogen from 5.2 (0.3) to 6.6 (0.3) mis (p<0.05), and increased the rate of amino acid stimulated urea synthesis from 27 (1) to 37 (2) jimols (p<0.05) pointing to increased hepatic removal of amino-nitrogen at expense of plasma amino-nitrogen. Infusion of somatostatin prevented increase of glucagon for 24 hours after surgery, and prevented the negative changes in postoperative nitrogen homeostasis resulting from the postoperative changes in hepatic nitrogen conversion, suggesting glucagon as mediator. The exact mechanism remains in doubt, however, because of the multiple effects of somatostatin. (Gut 1995; 36: 
Regulation of postoperative loss of body protein is not fully understood. The liver plays a primary part in the catabolic stress response after surgery. The hepatic effectiveness of conversion of plasma amino-nitrogen into urea nitrogen increases considerably (more than tissue amino-nitrogen release), so that the plasma amino-nitrogen decreases because of the depletion by the liver. 1 by the rate of urea synthesis. The priming consisted of an infusion of amino-nitrogen at a rate of 41.2 ,tmol min-lkg-1 body weight for 60 minutes, and the continuous infusion of an infusion for 180 minutes at a constant rate of 22.3 [umol min-kg-1 body weight.1 The amino acid infusion resulted in a total fluid volume of 500 ml.
Venous blood samples were drawn from the contralateral arm before start of the amino acid infusion and then every half hour.
Urine was collected quantitatively by voiding from the time when the amino acid infusion was started and every hour during infusion.
After the preoperative investigation, patients had free access to tap water and received for the rest of the day a diet containing 2000 kcal and 75 g of protein.
On the day of operation the patients received 2000 ml of isotonic saline intravenously, and on average 2500 ml of isotonic saline during the operation.
During the amino acid infusions no other infusion was given.
The patients in the experimental group received, in addition, a hormonal blockade started during induction of anaesthesia and maintained until the end of investigation -that is, for 30 hours after skin incision. Both groups received morphine intramuscularly, 10 mg every six to eight hours for relief of pain.
Blockade Natural somatostatin (SS28) (DuraScan Medical Products A/S, Denmark) was given as a bolus injection of 6 ,ug/kg-1 followed by a continuous infusion of 6 ,uglkg/h dissolved in isotonic saline.
There was no undesirable effect of the blockade concerning change in blood pressure, heart rate, or blood glucose.
Analyses Total a-amino-nitrogen concentration in plasma and urine was determined by the dinitroflourobenzene method13 (coefficient of variation of analysis 1-25%) and urea in blood and urine by the Urease-Berthelot methodl4 (coefficient of variation 1%). Blood 
The total body water (TBW) was estimated from body weight (BW, kg), body height (BH, cm), and age (Y, years), by the formulas19: TBW=0 3265BW+0 2239BH-0 138Y-14-47 for men and TBW= 0-2363BW+ 0 1 962BH -0-0272Y-10-26 for women.
L was taken to be 17%.20
The nitrogen exchange during steady state was calculated as the percentage of infused amino-nitrogen appearing as urea nitrogen by excretion plus accumulation.
Statistical analysis
Values are given as mean (SEM). Difference between groups was evaluated by two tailed t tests of means or pairs as appropriate. p Values smaller than 0.05 were considered statistically significant. 
Amino-nitrogen
The amino acid infusions increased the fasting plasma concentrations of total a-aminonitrogen by about 80% (Table I) . Postoperatively, the amino acid concentrations were about 20% lower in control patients (p<005), and 60% (fasting) and 25% (amino acid load) higher in the patients with blockade (p<0 01) (Table I) . Postoperatively, the plasma clearance of total a-amino-nitrogen increased by about 25% in the control group (p<0O05), and did not change in the blockade group (Fig 1) .
Urea synthesis
In the control group, surgery increased the amino acid stimulated rate of urea synthesis by one third (p<005). In the blockade group, surgery did not change the rate of urea synthesis (Fig 1) .
Preoperatively, 15% of the infused aminonitrogen was retained in the body, and postoperatively in the control group 15% more was excreted than infused (p<0 02). The blockade prevented this postoperative loss of aminonitrogen (Fig 1) .
Glucose Surgery increased fasting blood glucose concentration by 25% (p<0 05) in the control group, without further increase during amino acid load (Table I ). In the blockade group surgery increased the fasting concentration by 30% (p<005), and the amino acid load increased it further by 1 0% (Table I) .
Hormones
Glucagon -preoperatively, the amino acid infusion increased plasma glucagon concentration by about 40/o over fasting in both groups (p<002). Postoperatively, glucagon more than doubled (p<0 001) in the control group, while it remained unchanged in the blockade group (Table II) . Postoperatively, the fasting value was 70% (p<0.05) higher than preoperatively in the blockade group. Somatostatin halved glucagon concentration for 12 hours after start of operation (Fig 2) whereafter the concentration rose to the preoperative value during amino acid load.
Insulin -preoperatively, the amino acid load did not change insulin in both groups, but doubled it after surgery (p<0 001) in controls, while it remained unchanged in the blockade group. In the blockade group insulin was halved (p<005) for 12 hours after which it rose to preoperative values (Table II, Fig 2) .
Cortisol -surgery increased fasting cortisol by 75% (p<005) and the amino acid load decreased it by 25% (p<005) postoperatively in controls. In the blockade group cortisol doubled from four to 12 hours after surgery, but was normal after 24 hours (Table II, Fig 2) .
Discussion
Somatostatin prevented the hepatic catabolic response to cholecystectomy.
The increase in the control group of urea synthesis at lower amino acid concentration after surgery reflects changes in liver function with regard to amino-nitrogen disposal -that is, more urea was synthesised and more aminonitrogen was lost for protein synthesis. Postoperatively, glucagon, cortisol, and catecholamine concentrations increased. Glucagon directly increases the hepatic efficacy for urea synthesis,9 10 and cortisol increases the capacity of urea synthesis in rats 1 and acts permissively for the effects of glucagon on urea synthesis.2' Catecholamines have no effect in themselves on urea synthesis22 but seem to act permissively for the effects of cortisol.23 Prostaglandins interact with the catabolic hormones and accelerates the hepatic catabolic response.24-26 Cytokines seem to accelerate hepatic synthesis of acute phase proteins27 and increase plasma glucagon and cortisol to concentrations as seen after stress.28 29 Other hormones such as human growth hormone7 and anabolic steroids30 have been shown to improve postoperative nitrogen economy, but it is not known whether the effects of these hormones entail changes in liver function.
Somatostatin blocks pancreatic release of glucagon and insulin. Triple infusion, however, of the traditional catabolic hormones (glucagon, cortisol, and catecholamines) to healthy humans only elicits a catabolism that is much less severe than in postoperative situations,3-5 suggesting that other factors are also important. Cytokines (tumour necrosis factor, interleukin 1 and 6) are among the prime candidates. Infusion of these cytokines, as just one of numerous other effects, reproduces the increased concentrations of both glucagon and cortisol as measured after surgery. [27] [28] [29] This suggests that the cytokines either initiate or comediate the postoperative change in nitrogen homeostasis by changes in the traditional catabolic hormones. The effect of somatostatin infusion on the cytokine response is not known but the blockade may modify hormonal changes secondary to cytokine stimulation. Somatostatin also inhibits the release of several gastrointestinal peptides such as gastrin, secretin, cholecystokinin, vasoactive intestinal peptide, and pancreatic polypeptide.38 39 However, any influenze of these hormones on urea synthesis has never been shown. Furthermore, somatostatin reduces hepatic blood flow by 12-25%,40 41 which may contribute to down regulate hepatic aminonitrogen conversion, but such changes cannot account for the total effect of somatostatin.
The increased urea synthesis shows that the decrease in amino-nitrogen concentration after surgery was mainly the result of removal by the liver. This is primarily caused by decreases of the gluconeogenic amino acids alanine, arginine, glutamate, glycine, proline, serine, and the two essential amino acids lysine and threonine. ' 2 The slight postoperative hyperglycaemia is caused by increased gluconeogensis42 and peripheral insulin resistance43 and was not affected by the blockade. Glucose suppresses urea synthesis mainly by decreasing glucagon,44 and spares some nitrogen postoperatively45, but the effect is limited by the insulin resistance.42 The normalisation of the hepatic amino-nitrogen conversion during the blockade and the relative hypoinsulinaemia is, therefore, not explained by the hyperglycaemia.
In conclusion, our study shows that the negative changes in postoperative nitrogen homeostasis resulting from increased hepatic efficacy for urea synthesis are preventable by somatostatin infusion. This suggests glucagon as a mediator. The exact mechanism of the inhibition remains uncertain, however, because of the multiple effects of the somatostatin infusion. A possible clinically beneficial effect of somatostatin in this situation awaits further studies.
